Clinical Trial Update: ASURE: Alzheimer Study Using oRal Edaravone [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial (ASURE) evaluating oral edaravone for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• oral edaravone (edaravone)

Snippet

Sponsor: Treeway B.V. | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED